INDV vs UNH

INDV presents a stark contrast between severe balance sheet fragility and explosive operational growth. While the Piotroski F-Score of 2/9 and a negative Price/Book ratio indicate significant financial health risks and potential insolvency concerns, these are offset by a massive 376.20% YoY earnings growth and a highly attractive forward P/E of 10.03. The stock is currently trading at a significant discount to its growth-based intrinsic value of $48.38, supported by a 'strong_buy' analyst consensus.

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.